1067 Cresthaven Road
Memphis, TN 38119
Tel: 901.761.0200
Fax: 901.761.2944
User Name:
Password:
 
  
 
Medical Liability Reform is More Than Caps
Tennessee's health care crisis is the basis of much debate.
Source: Tennessee Medical Association - 05/01/2007
 
MedWorm: Consumer Health News
Unlocking the genetic secrets of autism
It's been known Autism runs in families, but the underlying genetic determinants have been elusive. But a Nature article offers new insights, showing each individual carried his or her own unique assortment of mutations. (Source: CTV Health)

MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.
Source: CTV Health - Sat, 31 Jul 2010 11:24:57 +0100
Battle to control Rs.7 bn Lilavati Hospital hots up
The ongoing family feud for control over the estimated seven billion-rupee business empire linked to the Lilavati Hospital & Research Centre here Saturday took a new turn with a top trustee hitting out at others. (Source: The Economic Times)
Source: The Economic Times - Sat, 31 Jul 2010 11:19:36 +0100
Gene variant role in Parkinson's uncovered
An RNA fragment known to be implicated in Parkinson's has been shown to cause the death of neurons in the brains of fruit flies (Source: New Scientist - Health)
Source: New Scientist - Health - Sat, 31 Jul 2010 11:01:03 +0100
Integrated Approach Needed to Reduce TB Deaths in Those With HIV
Tuberculosis remains the leading cause of death in those with HIV, accounting for 25% of HIV-related deaths. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - Sat, 31 Jul 2010 10:06:00 +0100
GSK Receives CHMP Positive Opinion For A New Indication For Arixtra
GlaxoSmithKline (GSK) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Arixtra (fondaparinux),an anti-clotting drug (antithrombotic) for the treatment of adults with acute symptomatic spontaneous superficial-vein thrombosis (SVT) of the lower limbs without concomitant deep-vein thrombosis. "We are very glad that healthcare providers now have fondaparinux as a licensed treatment option for patients with superficial vein thrombosis... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - Sat, 31 Jul 2010 08:00:00 +0100
Bristol-Myers Squibb National Survey Finds A Disparity Between Health Care Providers And HIV Positive Patients
Bristol-Myers Squibb Company (NYSE: BMY) presented results from a national survey which found that emotional barriers, such as stigma, fear, denial and shame, and structural barriers, such as lack of knowledge, transportation, and insurance coverage, can prevent people living with HIV/AIDS (PLWHA) from seeking care and treatment. These data further the understanding of obstacles to care for many PLWHA and may help address the gap between a person testing HIV positive and seeking medical care and treatment in the United States... (Source: Health News from Medical News Today)

MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.
Source: Health News from Medical News Today - Sat, 31 Jul 2010 08:00:00 +0100
Eisai Announces U.S. Fda Approval For New Higher Dose Aricept® 23 Mg Tablet For The Treatment Of Moderate-To-Severe Alzheimer's Disease
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for Aricept® (generic name: donepezil hydrochloride) 23 mg once daily tablet for the treatment of moderate-to-severe Alzheimer's disease (AD). Aricept® 23 mg tablet offers another dosing option for patients with moderate-to-severe AD for whom few treatments are available. Approximately 3.6 million Americans age 65 and older suffer with moderate-to-severe AD... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - Sat, 31 Jul 2010 08:00:00 +0100
Biogen Idec And Swedish Orphan Biovitrum Present Data On Long-Lasting Hemophilia B Therapy At The World Federation Of Hemophilia Congress
Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (STO: SOBI) announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies' long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients. The data, which were presented at the World Federation of Hemophilia Congress in Buenos Aires, Argentina, on July 11, 2010, showed that rFIXFc was well tolerated and demonstrated an approximately three-fold increase in half-life compared to historical data for existing therapies... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - Sat, 31 Jul 2010 08:00:00 +0100
Interactive Health Solutions Launches New Program With Physicians To Reduce Medical Costs
According to Interactive Health Solutions, Inc. (IHS, interactivehs.com), 63% of adults have not seen a doctor within five years. In order to help battle ever-rising healthcare costs, IHS announced the introduction of Physician Link™ this week a revolutionary program connecting members to their physician, and wellness team, through an integrated communication process... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - Sat, 31 Jul 2010 08:00:00 +0100
Hotspur Technologies Receives FDA 510(k) Clearance For First Three Product Lines Based On The Company's Unique Technology
Hotspur Technologies, Inc. announced that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - Sat, 31 Jul 2010 08:00:00 +0100
 
Home   About Us   Patients   Physicians   Disclaimer
@2010 - Memphis Medical Society ~ Site by FullNet247